-
Active Ingredient:Paracetamol
-
Content Specification:160mg Paracetamol per 5mL, total volume 60mL per bottle
-
Pharmaceutical Form:Oral Suspension
-
Applicable Standard:International pharmacopoeia specification, daily health care grade
-
Storage Condition:Sealed storage, protected from light and high temperature, kept in a cool and dry ventilated environment
-
Product Features:Fine suspension texture, mild and easy to take, stable property, portable packaging, safe for daily use, suitable for family health reserve and batch procurement
Package:
Product Description
Product Overview
Paracetamol Oral Suspension 160mg/5mL 60mL is a mild daily physical conditioning oral preparation with stable and gentle properties. It helps improve abnormal body temperature state and relieve common mild physical discomfort, bringing comfortable physical adjustment experience.
Paracetamol Oral Suspension 160mg/5mL 60mL: What the Published Guidance Says
The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.
This page collects the supply-relevant facts for Paracetamol Oral Suspension 160mg/5mL 60mL — specification, testing, packaging and the registration paperwork that travels with the batch.
- A strength-confusion warning that matters commercially The Model List itself warns that the presence of both 120 mg/5 mL and 125 mg/5 mL paracetamol oral liquid strengths on the same market would cause confusion in prescribing and dispensing and should be avoided. Country programmes should therefore settle on one strength. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- The Model List specifies the exact presentations Section 2.1 of the 24th WHO Model List (2025) lists acetylsalicylic acid (suppository 50–150 mg; tablet 100–500 mg), ibuprofen (oral liquid 100 mg/5 mL; tablet 200, 400 and 600 mg) and paracetamol (oral liquid 120 mg/5 mL or 125 mg/5 mL and 250 mg/5 mL; suppository 100 and 250 mg; tablet 250, 325 and 500 mg; dispersible tablet 100 and 250 mg). WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Fever control is part of severe-disease management MSF guidance on severe malaria directs paracetamol in the event of high fever only — a reminder that in febrile illness the antipyretic is supportive care, not the disease treatment. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Paracetamol Oral Suspension 160mg/5mL 60mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Supply & Specification Data for Paracetamol Oral Suspension 160mg/5mL 60mL
| Therapeutic group | Analgesics & NSAIDs — Analgesics & NSAIDs |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ibuprofen Oral Suspension 100mg/5mL 60mL, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Paracetamol Suppository 150mg, Diclofenac Sodium 50mg, Mefenamic 250mg Capsules, Aspirin 300mg Tablets.
Testing, Monographs & Batch Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Paracetamol Oral Suspension 160mg/5mL 60mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The batch record for this product normally includes:
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Pack Configuration, Artwork & Shipping Documents
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Dossier, Authority Filings & Tender Documentation
Documents for Paracetamol Oral Suspension 160mg/5mL 60mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
The context for Paracetamol Oral Suspension 160mg/5mL 60mL is its place among non-opioid analgesics and NSAIDs named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Buyer Questions about Paracetamol Oral Suspension 160mg/5mL 60mL
How is Paracetamol Oral Suspension 160mg/5mL 60mL packaged?
Suspension presentations are quoted to your pack specification, with the artwork, pack size and labelling language confirmed before manufacture.
What documentation comes with a shipment of Paracetamol Oral Suspension 160mg/5mL 60mL?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Paracetamol Oral Suspension 160mg/5mL 60mL support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Do you supply paracetamol suppositories?
Yes — 150 mg and paediatric strengths. The Model List specifies suppository strengths of 100 mg and 250 mg, and national formularies frequently add intermediates.
Is diclofenac on the WHO Essential Medicines List?
No. The non-opioid analgesics named in section 2.1 are acetylsalicylic acid, ibuprofen and paracetamol. We supply diclofenac sodium in injectable and capsule form for markets whose national lists include it.
Other Analgesics & NSAIDs Products in This Range
- Ibuprofen Oral Suspension 100mg/5mL 60mL — 100mg/5mL
- Ibuprofen Suppository 50mg — 50mg
- Indomethacin Suppository 100mg — 100mg
- Naproxen Suppositories 250mg — 250mg
- Paracetamol Suppository 150mg — 150mg
- Diclofenac Sodium 50mg — 50mg
Browse the full Analgesics & NSAIDs range; all Suspensions; the complete product catalogue.
Request a Quotation for Paracetamol Oral Suspension 160mg/5mL 60mL
For tenders and programme supply, send the line item, pack size, quantity and destination for Paracetamol Oral Suspension 160mg/5mL 60mL 160mg/5mL. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
- WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
